Miles Report issue

Contributed to NME For profit Phase 1
Founded: Elkhart IN United States (1884)
Status: Acquired by Bayer (1979)

Organization Overview

First Clinical Trial
1999
NCT00000738
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MILES

Indications

Approved Indications


 

Diphyllobothriasis

Hymenolepiasis

Taeniasis

Experimental Indications (Clinical Trials, Phases 1-4)


 

AIDS Dementia Complex (Phase 1)

Dementia (Phase 1)

Neurologic Manifestations (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2